Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10657.32 Crore to Sales Value (93.84 % of Total Sales), Other Services which contributed Rs 374.24 Crore to Sales Value (3.29 % of Total Sales), Export Incentives which contributed Rs 250.66 Crore to Sales Value (2.20 % of Total Sales) and Other Operating Revenue which contributed Rs 74.10 Crore to Sales Value (0.65 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4296.90 Crore, down -1.35 % from last quarter Sales of Rs 4355.83 Crore and up 10.43 % from last year same quarter Sales of Rs 3890.93 Crore Company has reported net profit after tax of Rs -124.40 Crore in latest quarter. The company’s top management includes Dr.K U Mada, Dr.Kamal K Sharma, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Deshbandhu Gupta, Mr.R A Shah, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Christine Mundkur, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditors. As on 30-06-2019, the company has a total of 452,590,752 shares outstanding.
Download The Economic Times News App to get Daily Market Updates & Live Business News.